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Abstract
Background: Around 5–15% of all hospital patients worldwide suffer from healthcare-associated infections (HAIs),
and years of excessive antimicrobial use in human and animal medicine have created emerging antimicrobial
resistance (AMR). A considerable amount of evidence-based measures have been published to address these
challenges, but the largest challenge seems to be their implementation.
Methods: In June 2017, a total of 42 experts convened at the Geneva IPC-Think Tank to discuss four domains in
implementation science: 1) teaching implementation skills; 2) fostering implementation of IPC and antimicrobial
stewardship (AMS) by policy making; 3) national/international actions to foster implementation skills; and 4)
translational research bridging social sciences and clinical research in infection prevention and control (IPC) and
AMR.
Results: Although neglected in the past, implementation skills have become a priority in IPC and AMS. They should
now be part of any curriculum in health care, and IPC career paths should be created. Guidelines and policies
should be aligned with each other and evidence-based, each document providing a section on implementing
elements of IPC and AMS in patient care. International organisations should be advocates for IPC and AMS, framing
them as patient safety issues and emphasizing the importance of implementation skills. Healthcare authorities at
the national level should adopt a similar approach and provide legal frameworks, guidelines, and resources to allow
better implementation of patient safety measures in IPC and AMS. Rather than repeating effectiveness studies in
every setting, we should invest in methods to improve the implementation of evidence-based measures in different
healthcare contexts. For this, we need to encourage and financially support collaborations between social sciences
and clinical IPC research.
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Conclusions: Experts of the 2017 Geneva Think Tank on IPC and AMS, CDC, and WHO agreed that sustained efforts
on implementation of IPC and AMS strategies are required at international, country, and hospital management
levels, to provide an adequate multimodal framework that addresses (not exclusively) leadership, resources,
education and training for implementing IPC and AMS. Future strategies can build on this agreement to make
strategies on IPC and AMS more effective.
Keywords: Implementation, Infection prevention and control, International, National, Institutional, Change, CDC,
ECDC, WHO
Background
Around 5–15% of hospital patients worldwide suffer
from healthcare-associated infections (HAIs) [1]. Years
of excessive antimicrobial use in human and animal
medicine have selected multidrug-resistant microorgan-
isms, which have led to untreatable infections, often in
vulnerable patient populations [2, 3]. This amounts to a
global crisis that requires urgent actions in infection pre-
vention and control (IPC) and antimicrobial stewardship
(AMS) [4]. The European Centre for Disease Prevention
and Control (ECDC) and the World Health
Organization (WHO) have identified key/core compo-
nents for effective organization of IPC at the facility
(Table 1) and national levels (Table 2) [5–7]. Both IPC
and combating antimicrobial resistance (AMR) are in
national action plans in the Unites States [8], and other
countries [9], and, WHO, together with the Food and
Agriculture Organization (FAO) of the United Nations
and the World Organisation for Animal Health (OIE),
has issued a global action plan on AMR in 2015 that
member states committed to adapt as national action
plans [10, 11]. Thus, commitment at the highest national
and international levels is already in place.
Under the auspices of the US Centers for Disease Con-
trol and Prevention (CDC), the WHO, and the University
of Geneva Hospitals and Faculty of Medicine (HUG), an
international panel of 42 experts with backgrounds in
IPC, microbiology, infectious diseases, public health,
psychology, medical technology, and social sciences, con-
vened for 2 days at the Geneva Think Tank on IPC and
AMR in June 2017 (2017 Geneva IPC-Think Tank) to de-
velop a vision on IPC and the prevention of AMR, and to
agree on a road map for research and public health activ-
ities. Three dimensions on IPC and AMS were discussed:
1) implementation of IPC and AMS; 2) technology in IPC
and AMS; and 3) broadening the global IPC network. This
is the first in a series of three papers summarising the dis-
cussions at the 2017 Geneva IPC-Think Tank; it focuses
on implementation of IPC and AMS.
Methods
Four domains related to implementation of IPC and
AMS were addressed: 1) teaching implementation skills
to IPC professionals; 2) integrating implementation
strategies in policy making on IPC and AMS; 3) na-
tional/international actions to support implementation
of IPC and AMS; and 4) translational research bridging
social sciences and research in IPC and AMS. After a
presentation on the principles of implementation science
and the ECDC IPC key components, and after a short
introduction to the four domains to be discussed, the ex-
perts were allocated into four focus groups. The groups
discussed each of the four domains for 30 min. The dis-
cussions were guided by a moderator, tape recorded, and
writers took notes. The goal was to obtain a broad in-
ventory of thoughts; the experts were invited to express
their opinion and concerns towards the discussed do-
mains. Summaries from the discussion rounds were
shared in a plenary session.
Results
Participants expressed both interest and general agree-
ment with the principles of implementation research in
IPC and AMS. The following paragraphs summarize as-
pects of implementation in IPC and AMS which were
discussed in the discussion rounds, and examples, which
were mentioned by the participants.
Teaching “implementation” to IPC professionals
Implementation skills are important and should be inte-
grated in the education of IPC and AMS. Flexible ap-
proaches to implementation informed by social science
are the most valuable, in contrast to cookbook ap-
proaches or checklists, which risk being simplistic: fos-
tering tick-boxing, rather than context specific, adapted,
actions. HUG, to cite one example, has included training
on “implementation” in its annual international course
on implementation in IPC since 2014. The course fol-
lows a social sciences approach aiming at both sensitiz-
ing participants to the complexity of implementation
research, and providing practical directions on tailoring
implementation strategies in daily practice. The course
is based on the “consolidated framework for implemen-
tation research” (CFIR) [12]. CFIR is a meta-theory,
mapping several theories in implementation research to
five dimensions: the intervention itself (to be adapted to
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the local context), the process of intervention (planning, en-
gaging, executing, evaluating), the individuals involved in
the intervention (personal beliefs, capacity, perceptions),
the organizational context (structural and societal architec-
ture), and determinants external to the organization (geog-
raphy, culture, politics, healthcare system). The interplay of
these dimensions is intuitive, and the practical explanations
of the determinants given by the authors help IPC profes-
sionals to navigate through the dimensions.
Basic principles of implementation should be taught in
undergraduate training, not only to IPC professionals,
but to all healthcare professionals. Medical education
could be supplemented to enable students to develop a
more thorough understanding of social science and its
contribution to knowledge about improvement and im-
plementation. Training on implementation skills is a pri-
ority across low-and-middle-income (LMIC) and
high-income countries. The need to accelerate discus-
sion on the principles of implementation in IPC and
AMS is not a luxury restricted to the “first” world nor is
it a fad solely for researchers interested in social science.
Implementation challenges that stop the translation of evi-
dence into practice are real and apply everywhere. Educa-
tion on any IPC or AMS activity should incorporate an
implementation strategy. The IPC community should agree
on the principles of implementation, and distinguish basic
and advanced skills. Low-and-middle-income countries
with limited access to skills platforms could benefit from
e-learning resources provided or endorsed by international
organizations and IPC societies. WHO has indeed made
available, both as face-to-face training and as e-learning
packages, a training module on “Leadership and
programme management in infection prevention and con-
trol” which is deeply rooted in implementation science [13].
Table 1 Key and core components for effective infection prevention and control in health care facilities
Key components (ECDC) [5] Core components (WHO) [6]
1 An effective infection control program in an acute care hospital must
include at least: one full-time specifically trained IPC nurse per 250 beds;
a dedicated physician trained in IPC; microbiological support; data man-
agement support.
An IPC program with a dedicated, trained team should be in place in
each acute healthcare facility for the purpose of preventing HAI and
combating AMR through IPC good practices.
2 To make sure that the ward occupancy does not exceed the capacity
for which it is designed and staffed; staffing and workload of frontline
healthcare workers must be adapted to acuity of care; and the number
of pool/agency staff minimized.
In order to reduce the risk HAI and the spread of AMR, the following
should be addressed: 1) bed occupancy should not exceed the
standard capacity of the facility; 2) healthcare worker staffing levels
should be adequately assigned according to patient workload.
3 Sufficient availability of and easy access to material and equipment and
optimized ergonomics.
At the facility level, patient care activities should be undertaken in a
clean and/or hygienic environment that facilitates practices related to
the prevention and control of HAI, as well as AMR; including all
elements around the WASH infrastructure and services and the
availability of appropriate IPC materials and equipment.
4 Use of guidelines in combination with practical education and training. Evidence-based guidelines should be developed and implemented for
the purpose of reducing HAI and AMR. Education and training of the
relevant healthcare workers on guideline recommendations should be
undertaken to achieve successful implementation.
5 Education and training involves frontline staff, and is team- and task-
oriented.
At the facility level, IPC education should be in place for all healthcare
workers by utilizing team- and task-based strategies that are participa-
tory and include bedside and simulation training to reduce the risk of
HAI and AMR.
6 Organizing audits as a standardized (scored) and systematic review of
practice with timely feedback.
Regular monitoring/audit and timely feedback of healthcare practices
should be undertaken according to IPC standards to prevent and
control HAIs and AMR at the healthcare facility level. Feedback should
be provided to all audited persons and relevant staff.
7 Participating in prospective surveillance and offering active feedback,
preferably as part of a network.
Facility-based HAI surveillance should be performed to guide IPC
interventions and detect outbreaks, including AMR surveillance with
timely feedback of results to healthcare workers and stakeholders and
through national networks.
8 Implementing IPC programs follows a multimodal strategy including
tools such as bundles and checklists, developed by multidisciplinary
teams and taking into account local conditions.
At the facility level, IPC activities should be implemented using
multimodal strategies to improve practices and reduce HAI and AMR.
9 Identifying and engaging champions in the promotion of a multimodal
intervention strategy.
NA
10 A positive organisational culture by fostering working relationships and
communication across units and staff groups.
NA
AMR, Antimicrobial resistance; ECDC, European Centre for Disease Prevention and Control; HAI, Healthcare-associated infection; IPC, Infection prevention and
control; NA, not applicable; WASH, Water, sanitation and hygiene; WHO, World Health Organization
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Also, social media could help promote knowledge. Par-
ticularly in LMICs, where smart phones can be found even
in remote domains, social media may help in communica-
tion, education and training. Implementation (science)
should become part of IPC certificates, as is the case already
with the “European Certificate for Infection Control”
(EUCIC) [14], established by the European Society for Clin-
ical Microbiology and Infectious Diseases (ESCMID).
EUCIC has integrated the HUG implementation course in
its IPC curriculum. WHO or CDC could create a “model
curriculum” for the implementation of strategies on IPC
and AMS; in line with the “model legislation” it already pro-
poses for Member States in some domains. Activities should
be coordinated with multi-level partners, professional/civil
societies and initiatives in related fields, e.g. antimicrobial re-
sistance or water, sanitation and hygiene (WASH).
Promoting implementation of strategies on IPC and AMS
in policy making
Policies and guidelines on IPC and AMS are technical
documents, issued by international organisations, national
bodies and professional societies [15–19]. They are refer-
ence documents based on the evidence-base offering de-
tails on best clinical practice, and effective interventions
and programmes. The term “implementation” is found in
all of them, but as an advice (do it) rather than a concept
(how to do it). WHO IPC guidelines and selected profes-
sional guidelines offer a perspective on “how” to imple-
ment recommendations [20, 21], but only a few have
detailed sections on the subject [22–24]. Policies can sup-
port the implementation process on various levels: first,
policies can offer practical information on implementa-
tion; second, policies can promote IPC and AMS as
Table 2 Core components for infection prevention and control at the national level
National core components (WHO) [6]
1b Active, standalone national IPC programs with clearly defined objectives, functions and activities should be established for the purpose of
preventing HAI and combating AMR through IPC good practices. National IPC programmes should be linked with other relevant national
programmes and professional organizations.
2 Evidence-based guidelines should be developed and implemented for the purpose of reducing HAI and AMR.
Education and training of relevant healthcare workers on the guideline recommendations and the monitoring of adherence with guideline
recommendations should be undertaken to achieve successful implementation.
3b National IPC programs should support the education and training of the health workforce as one of its core functions.
4b National HAI surveillance programs and networks including mechanisms for timely data feedback and with the potential to be used for
benchmarking purposes should be established to reduce HAI and AMR.
5b National IPC programs should coordinate and facilitate the implementation of IPC activities though multimodal strategies on a nationwide or
sub-national level.
6b National IPC monitoring and evaluation programs should be established to assess the extent to which standards are being met and activities are
being performed according to the programs’ goals and objectives. Hand hygiene monitoring with feedback should be considered as a key
performance indicator at the national level.
AMR, Antimicrobial resistance; HAI, Healthcare-associated infection; IPC, Infection prevention and control; WHO, World Health Organisation
Table 3 Actions to facilitate implementation in infection prevention and control and antimicrobial stewardship
Level Action
International level - Make IPC a global priority – take the lead
- Support global IPC initiatives
- Provide minimal standards in patient safety
- Provide guidance (key/core components)
National level - Make IPC a national priority – have a national strategy
- Provide career paths for IPC professionals
- Promote IPC and AMS, as well as their implementation, being part of education and training for all healthcare
professionals
- Provide national guidelines and policies, aligned with international standards
- Organise surveillance of process and outcome indicators, benchmark with other countries
- Make resources available (education and training, materials, staffing)
Health care facility
level
- Make IPC an institutional priority – have a local strategy
- Provide resources
- Allow postgraduate training in IPC and AMS as well as their implementation
IPC community - Integrate implementation science, management, and leadership in the curriculum of IPC training
- Make implementation science an ongoing topic on the agenda of any IPC workshop
Research - Add an implementation narrative to any publication on best practice interventions
- Encourage collaboration between IPC researchers and social scientists to improve study design and reporting
- Provide funding of mixed-methods research on behaviour change interventions
AMS, Antimicrobial stewardship; IPC, Infection prevention and control
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patient safety priorities; third, policies can define responsi-
bilities and accountability surrounding best practice
actions:
1. Each policy needs an implementation strategy with
practical advice on project adoption (making it an
organisational priority), project management, and
education and training. When developing IPC
guidelines, WHO develops solid implementation
strategies and tools based on expert input from the
field concurrently. The first, insightful example was
its guideline on hand hygiene [22], accompanied by
an innovative multimodal implementation strategy
[25], and a number of practical tools to be used to
facilitate recommendations’ adoption (http://www.
who.int/infection-prevention/tools/hand-hygiene/
en/). The intervention was pilot-tested in selected
institutions worldwide, and tools were modified or
adapted for optimal adoption of the change strategy
[26]. Another example is the “Strategies to prevent
central line-associated bloodstream infections in
acute care hospitals” document issued by the Infec-
tious Diseases Society of America (IDSA) in collab-
oration with the Society for Healthcare
Epidemiology of America (SHEA), which included a
section on implementation to their document [27].
2. Policies and guidelines should explain the purpose
of the document, and how it is intended to be used
within the health system [21]. They should discuss
the magnitude of the problem and why it needs to
be addressed [27]. Although IPC and AMS policies
are about quality assurance, they promote “patient
safety” actions. This is more than just a semantic
detail; the term “safety” has more weight than
“quality” and helps IPC professionals to get the
attention of hospital managers, department leaders,
and even the public. The strongest incentive to
encourage hospitals to implement policies is when
they become law, as has happened, for example,
in Germany with the recommendations of the
“Kommission für Krankenhaushygiene und
Infektionsprävention” of the Robert Koch
Institute [28].
3. Detailing and scope varies in guidelines, policies
and recommendations. Some documents focus on
best practice actions alone as if there was no
context [15]. Others on the other hand, put best
practice actions into a wider context addressing
surrounding conditions such as accountability, non-
technical interventions, and surveillance with timely
feedback. Policies should define the responsibilities
and accountability of the different stakeholders in-
volved in IPC and AMS: from hospital manager to
frontline worker [27]. Clear roles help IPC
professionals communicate in the implementation
process. Establishing surveillance with target setting
(in combination with public reporting) enhances
the value of a policy. Whether rewards or penalties
(or both) are applied to achieve improvement de-
pends on the national and organizational context
(culture and law). Policies and guidelines have a role
in bringing together AMS and IPC to avoid imple-
mentation problems that arise from treating them
as separate topics.
Guidelines issued by international organisations, na-
tional bodies and professional societies are often not
consistent [29]. Consistency and minimal standards set
by international organisations such as CDC, ECDC or
WHO would be helpful in this context. The key/core
components published by ECDC and WHO already set
the directions of successful IPC strategies [5, 6]. How-
ever, these strategies do not replace detailed policies,
which need to be contextualised for each country.
Ideally, national and local policies should be checked
against international standards, contextually grounded,
and provide tangible information about how to establish
the recommendations. Not all countries, however, have
the resources to build local guidelines: LMICs in par-
ticular tend to rely on international documents. There-
fore, international organisations should aim to integrate
the significance of local or regional contexts into the im-
plementation sections. For example, WHO uses specific
approaches to gather country and facility examples, in-
cluding a focus on settings with limited resources, to de-
velop its implementation manuals and resources [30,
31]. Allowing for adaptation is key to successful adop-
tion by front line workers. If significant resources are re-
quired for a prevention strategy, policy makers should
address this explicitly and discuss how implementation
can be financed. In cases where urgent action would be
required (e.g. outbreak situations), innovative resource
allocation may be needed (e.g. ex-post reimbursement).
Descriptions of implementation strategies should be
packaged as structured, easy-to-read, protocols or man-
uals, and also published in the internationally available
peer-reviewed literature. Ideally, guidelines, implementa-
tion strategies and tools for implementation should be
translated into local languages.
Activities at the national and international level
At the national level, authorities should be concerned
about HAIs and AMR, and reposition IPC and AMS in
national strategies. Indeed, this has been done in various
countries in recent years. The role of policy makers at
national level is not to enforce implementation as such,
but to support implementation through political direc-
tion, legislation, and budget allocation. Today, IPC is
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perceived as a cost centre. This must change, and stake-
holders need to accept the cost-benefit advantages of
giving priority to patient safety. Political support helps
IPC professionals in implementation at the institutional
level. National IPC bodies should be established to co-
ordinate activities with clearly defined tasks. Their work
should involve different stakeholders, and they should be
part of an international network. Clarifying the specific
roles and responsibilities is critical. Health authorities or
IPC bodies should promote awareness of IPC and AMS
in the general public, by fostering patient engagement
and encouraging media involvement. This can be
achieved by using patient stories (giving patients a
voice), or engaging marketing companies to promote
prevention measures or judicious antimicrobial use.
On the international level, actions towards implemen-
tation are more about advocacy. There should be coord-
ination and agreement on achievable aims and goals for
IPC and AMS. Networking between countries should be
encouraged. The activities of the ARHAI (antimicrobial
resistance and healthcare-associated infection) network
of ECDC and those of CDC and WHO in the context of
the Global IPC Network are good examples. Leadership
provided at international level, e.g. by CDC, ECDC, or
WHO, helps to prioritise IPC and AMS within national
budget discussions. In addition to education and train-
ing, for LMICs, it is necessary to establish funding
mechanisms for materials delivered by international or-
ganisations. However, independent funding may face the
challenge of sustainability. For both LMICs and
high-income regions, the main task of international or-
ganisations is to prioritise and promote IPC and AMS.
This sends a positive signal and facilitates implementa-
tion at institutional level. International ambassadors can
further sensitize institutions and governments to the
cause of IPC and AMS.
Translational research
Evaluation of interventions can be challenging as in
some instances, infections decrease already before the
formal start of an intervention [32], or secular trends are
stronger than the effect of a prevention programme [33].
There is strong evidence for the effectiveness of behav-
ioural change interventions in IPC, whether they are
bundled or non-bundled, and evidence indicates that im-
plementation should follow a multimodal or multifa-
ceted strategy [5, 34]. The challenge now is to learn
more about the implementation of these types of inter-
vention [35]. Requesting more detailed information on
published interventions, and particularly about how in-
terventions were implemented against organisational
barriers would be valuable. The narrative of such detail-
ing can help identify if a certain intervention is more or
less likely to be replicated in a specific context. Over
recent years, there has been growing collaboration be-
tween IPC professionals and social scientists to better
understand the dynamics of implementing behavioural
change interventions in IPC and AMS [32, 33, 36–39].
Methodologies used in qualitative social science research
can help improve understanding. Ideally, mixed-methods
studies, combining quantitative and qualitative research,
should be promoted.
Discussion
A perceived key challenge for IPC professionals today is
the lack of skills in applying scientific evidence favouring
specific healthcare practices in daily practice.
At the core of implementation research is the notion
that scientific evidence is not sufficient to promote
change in organisations [40]. This is because change is
achieved by individuals within the organisations, who
need to align new interventions and practices with their
own education, beliefs and perceptions, and the context
in which they work. Individuals are not passive recipi-
ents; they experiment with innovations, looking for
meaning within them; they develop positive or negative
feelings, and may challenge, worry or complain about
any changes they may choose to work with some innova-
tions while consciously or unconsciously avoiding
others; or they may try to modify, improve or redesign
an intervention – either on their own or by exchanging
with other stakeholders [41]. Implementation will be
shaped by organisational culture [42]: the array of
norms, values, and basic assumptions shared by the “en-
semble” of individuals. Like many other aspects of cul-
ture, organisational culture is stable, socially
constructed, and partly subconscious. Also, characteris-
tics of an institution and its social architecture (i.e. the
people forming a group and the coordination of the
group) are consequential: size, functional differentiation,
resources all impact on implementation of strategies on
IPC and AMS. The size and age of an organisation are
both negatively associated with implementation success
if bureaucratic structure is increased as a result. Power
dynamics, social relations and team structures have been
pinpointed as playing key roles in translating change
into practice in healthcare settings and many different
frameworks have been developed to structure the
various forces that come into play when a potential
change and an organisation come into contact with
each other [12].
Given the complexity of organisations and their ten-
dency to prefer the status quo, it is difficult for IPC profes-
sionals to implement IPC and AMS interventions that
affect a range of employees of various levels and profes-
sions. In the absence of subtle tactics targeting behavioural
change, implementation of best practice recommenda-
tions often follows two lines of argument: they are issued
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by a trusted authority, or they are issued with emphasis on
the fact that they are evidence-based. The evidence base
is, however, often ambiguous and contested and must be
continually interpreted and reframed in accordance with
priorities of the local context, a process that may involve
power struggles among various professional groups [43].
Thus, implementation does not automatically follow evi-
dence. Social scientists have contributed substantially to
understanding implementation – indeed, implementation
has become a science in its own right [12, 36, 41].
The 2017 Geneva Think Tank on IPC and AMS con-
firmed the importance of fostering implementation skills
in IPC and AMS, and how little attention this had been
given in the past. This is surprising because effective im-
plementation of best practices in IPC and AMS is a crit-
ical part of delivering patient safety and quality. Best
practices are effective, evidence-based procedures, per-
formed by healthcare professionals in a given context.
This context is influenced by hospital policy, organisa-
tional culture, resources, education and training, and per-
ceptions. Stakeholders on many levels are accountable for
patient safety, all within their domains of responsibility.
Table 3 summarises actions to facilitate implementation in
IPC and AMS, stratified by different stakeholder levels.
Countries should adopt an implementation-focused at-
titude, making the successful implementation of IPC and
AMS a national priority, collaborate with other countries
or international organisations, assure appropriate educa-
tion and training, make IPC a respected career path,
provide sufficient resources, and produce policies that
can be implemented at the various levels of health deliv-
ery. The situation in LMICs is dominated by a lack of re-
sources and infrastructures and organisational needs
that are not being met.
International organisations should make HAI-prevention
and AMS a priority. They also have a role to play by work-
ing with IPC and water, sanitation and hygiene (WASH)
professionals and institutions in LMICs through freely
accessible education and training modules and the develop-
ment, co-development and provision of practical, context-
ually relevant implementation tools. Research in IPC and
AMR should embrace qualitative research. Studies, most
often observational, should have an implementation narra-
tive, the story around barriers and facilitators and what
needs to be considered in order to succeed. This would
help to adapt prevention strategies to the local context or
to decide if a certain IPC or AMS implementation strategy
is suitable at all. Adaptation is key to better adoption of
IPC/AMS implementation at the patient bedside. We need
to collaborate with social scientists to improve the way pre-
vention strategies are designed, implemented and reported.
Advocacy should be done to convince donors about the im-
portance of research funding for qualitative research or
mixed-methods studies.
Conclusion
Experts of the 2017 Geneva Think Tank on IPC and
AMS, CDC, and WHO agreed that sustained efforts on
implementation of strategies on IPC and AMS is re-
quired at international, country, and hospital manage-
ment levels to provide an adequate multimodal
framework that addresses (not exclusively) leadership,
resources, education and training for implementing IPC
and AMS. Future strategies can build on this agreement
to make strategies on IPC and AMS more effective.
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